MedPath

Effects of low-carbohydrate diet on preferential abdominal fat loss for 6 months in type 2 diabetes

Not Applicable
Completed
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000003425
Lead Sponsor
Himoto Clinic
Brief Summary

The patients showed good compliance with the LCD (1812 +/- 375 kcal/day, % carbo-hydrate:fat:protein = 35:40:19 for men; 1706 +/- 323 kcal/day, % carbohydrate:fat:protein = 41:36:21 for women). Significant decreases (P = 0.05) in BMI and HbA1c levels were observed, along with an increase in HDL-C (P = 0.021) in men and a decrease in LDL-C (P = 0.001) in women. VAT (21.6 cm2, P < 0.001 in men;19.6 cm2;, P < 0.001 in women) and SAT (13.5 cm2, P = 0.004 in men;19.1 cm2, P = 0.003 in women) significantly decreased. The loss of VAT (%deltaVAT) was greater than that of SAT (%deltaSAT) in women (P = 0.022). A similar but not significant predominance of VAT loss was detected in men (P = 0.111). In women, the %deltaSAT significantly correlated with changes in FBG (deltaFBG) (r = 0.417) and HDL-C (deltaHDL) (r = 0.720), as was %deltaVAT with changes in triglyceride (deltaTG) (r = 0.591).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with serum creatinine levels > 1.5 mg/dl, severe diabetes complications (proliferative retinopathy, symptomatic neuropathy or diabetic foot), ketoacidosis, soft drink ketosis, cancer, severe heart failure and liver cirrhosis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Body mass index, visceral fat and subcutaneouse fat measured by CT, insulin, fasting blood glucose, HbA1c, total energy intake,%carbohydrate, %protein and %fat assessed by dietary food records(at baseline,after 3-month, after6- month).
Secondary Outcome Measures
NameTimeMethod
blood pressure, serum lipid profiles, albumin-creatinine ratio of spot urine(at baseline,after 3-month, after6- month).
© Copyright 2025. All Rights Reserved by MedPath